Skip to main content

Table 1 Comparison of patients’ demographic and clinical features before treatment

From: The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial

Groups

N

Gender (M/F, n)

Age (years)

Marital status (M/U/D)

Duration of illness (months)

Baseline BPRS

Ari.

39

21/18

26.31 ± 8.09

16/22/1

10.29 ± 13.29

54.49 ± 10.46

Ris.

43

22/21

32.37 ± 8.45

26/15/2

10.34 ± 15.67

54.12 ± 10.21

Que.

39

18/21

28.77 ± 8.31

19/17/3

4.41 ± 8.01

56.72 ± 11.46

Ola.

35

17/18

25.54 ± 6.93

15/19/1

9.29 ± 13.22

57.40 ± 14.90

Zip.

19

3/16

22.26 ± 5.41

7/12/0

7.31 ± 12.96

57.79 ± 15.34

χ 2/F

 

8.49

7.38

8.36

1.45

0.65

P value

 

> 0.05

< 0.01

> 0.05

> 0.05

> 0.05

  1. Values are represented as mean ± SD; N: number of patients; M/F: male/female; Ari.: aripiprazole; Ris.: risperidone; Que.: quetiapine; Ola.: olanzapine; Zip.: ziprasidone. M: married; U: unmarried; D: divorced